Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

17.22
Delayed Data
As of May 26
 0.00 / 0.00%
Today’s Change
11.60
Today|||52-Week Range
37.04
-10.73%
Year-to-Date
Baxalta Reports Positive Phase I Study Data on BAX 930
May 26 / Zacks.com - Paid Partner Content
Acorda Shelves Development of Epilepsy Treatment, Plumiaz
May 23 / Zacks.com - Paid Partner Content
Alkermes Begins Phase I Study on Immuno-Oncology Drug
May 26 / Zacks.com - Paid Partner Content
Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down
May 20 / Zacks.com - Paid Partner Content
Galapagos' RA Drug Filgotinib to Enter Phase III in 3Q16
May 25 / Zacks.com - Paid Partner Content
ImmunoGen Announces Phase I Cohort Ovarian Cancer Data
May 19 / Zacks.com - Paid Partner Content
AbbVie/Boehringer Report Crohn's Disease Drug Interim Data
May 25 / Zacks.com - Paid Partner Content
Bristol-Myers Reports Two-Year Overall Survival Opdivo Data
May 19 / Zacks.com - Paid Partner Content
Will Retrophin (RTRX) Continue to Surge Higher?
May 24 / Zacks.com - Paid Partner Content
Agios Strikes Metabolic Immuno-Oncology Deal with Celgene
May 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.22
Today’s open17.15
Day’s range16.93 - 17.27
Volume270,052
Average volume (3 months)516,691
Market cap$631.6M
Dividend yield--
Data as of 05/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-106.45%
Earnings growth (next 5 years)+138.00%
Revenue growth (last year)+254.19%
P/E ratio7.7
Price/Sales7.26
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-0.38-2.04%
NKNantKwest Inc-0.25-3.37%
ANIPANI Pharmaceuticals ...-0.40-0.77%
RLYPRelypsa Inc+0.41+2.53%
Data as of 05/26/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs